// App-Quantinova.ai

268 : Influence of preoperatively detected circulating tumor cells on the outcome of patients with urothelial carcinoma of the bladder treated with radical cystectomy.

Researchers

Presenter

  • Michael Rink

Principal Investigators

  • Armin Soave

  • Felix K. Chun

  • Shahrokh F. Shariat

  • Klaus Pantel

  • Margit Fisch

  • Sabine Riethdorf

  • Roland Dahlem

  • Sarah Minner

  • Luis A. Kluth

  • Sascha A. Ahyai

  • Hans Heinzer

  • Roman Heuer

  • Christian Eichelberg

  • Oliver Engel

Medical Centers

  • Weill Cornell Medical College, New York, NY

  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Locations

  • United States

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final